Company facts
- Founded
- 2024
- Headquarters
- Switzerland
About
Currently approved and clinical blood stem cell therapies rely on editing cells outside the body (ex-vivo). This involves extracting stem cells from the patient, editing them individually at specialized manufacturing facilities, administering high-dose chemotherapy to destroy existing bone marrow, and then transplantin…